These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16944412)

  • 1. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.
    Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F
    Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Habermeyer B; Fuhr P
    Pharmacopsychiatry; 2007 Mar; 40(2):87. PubMed ID: 17447184
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
    Walker RH; Danek A
    Pharmacopsychiatry; 2007 May; 40(3):132; author reply 132-3. PubMed ID: 17541893
    [No Abstract]   [Full Text] [Related]  

  • 4. Citalopram for OCD and Tourette's syndrome.
    Wehr AM; Namerow LB
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):740-1. PubMed ID: 11437010
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo.
    Stein DJ; Andersen EW; Overo KF
    Braz J Psychiatry; 2007 Dec; 29(4):303-7. PubMed ID: 18200396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder.
    Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C
    Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.
    Corregiari FM; Bernik M; Cordeiro Q; Vallada H
    Clinics (Sao Paulo); 2012; 67(4):335-40. PubMed ID: 22522758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of childhood obsessive-compulsive disorder with citalopram.
    Maud C; Stein DJ
    S Afr Med J; 1996 Jun; 86(6 Suppl):746, 748. PubMed ID: 9180769
    [No Abstract]   [Full Text] [Related]  

  • 11. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond depression: citalopram for obsessive-compulsive disorder.
    Pato MT
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S19-26. PubMed ID: 10471169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
    Wolmarans de W; Brand L; Stein DJ; Harvey BH
    Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].
    Jakitowicz J; Nowicki Z; Wiśniewski G
    Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
    Alaghband-Rad J; Hakimshooshtary M
    Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine for serotonin reuptake inhibitor nonresponder case of obsessive compulsive disorder.
    Aggarwal A; Jain M; Garg A; Jiloha RC
    Indian J Med Sci; 2009 Oct; 63(10):468-9. PubMed ID: 19901487
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood movement disorders and obsessive compulsive disorder.
    Swedo SE; Leonard HL
    J Clin Psychiatry; 1994 Mar; 55 Suppl():32-7. PubMed ID: 7915713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 20. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [
    Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.